Logo image of BYND

BEYOND MEAT INC (BYND) Stock Fundamental Analysis

NASDAQ:BYND - US08862E1091 - Common Stock

2.45 USD
+0.06 (+2.51%)
Last: 8/22/2025, 8:00:02 PM
2.53 USD
+0.08 (+3.27%)
After Hours: 8/22/2025, 8:00:02 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BYND. BYND was compared to 90 industry peers in the Food Products industry. BYND may be in some trouble as it scores bad on both profitability and health. BYND has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BYND had negative earnings in the past year.
BYND had a negative operating cash flow in the past year.
BYND had negative earnings in each of the past 5 years.
BYND had a negative operating cash flow in each of the past 5 years.
BYND Yearly Net Income VS EBIT VS OCF VS FCFBYND Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -22.20%, BYND is doing worse than 80.90% of the companies in the same industry.
Industry RankSector Rank
ROA -22.2%
ROE N/A
ROIC N/A
ROA(3y)-33.92%
ROA(5y)-25.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BYND Yearly ROA, ROE, ROICBYND Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

The Gross Margin of BYND (10.57%) is worse than 70.79% of its industry peers.
BYND's Gross Margin has declined in the last couple of years.
BYND does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.31%
GM growth 5Y-17.54%
BYND Yearly Profit, Operating, Gross MarginsBYND Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

BYND does not have a ROIC to compare to the WACC, probably because it is not profitable.
BYND has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BYND has been increased compared to 5 years ago.
The debt/assets ratio for BYND is higher compared to a year ago.
BYND Yearly Shares OutstandingBYND Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BYND Yearly Total Debt VS Total AssetsBYND Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

BYND has an Altman-Z score of -2.56. This is a bad value and indicates that BYND is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.56, BYND is not doing good in the industry: 83.15% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.56
ROIC/WACCN/A
WACC5.63%
BYND Yearly LT Debt VS Equity VS FCFBYND Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

A Current Ratio of 3.29 indicates that BYND has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.29, BYND belongs to the best of the industry, outperforming 85.39% of the companies in the same industry.
BYND has a Quick Ratio of 2.07. This indicates that BYND is financially healthy and has no problem in meeting its short term obligations.
BYND has a better Quick ratio (2.07) than 85.39% of its industry peers.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 2.07
BYND Yearly Current Assets VS Current LiabilitesBYND Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.66% over the past year.
BYND shows a decrease in Revenue. In the last year, the revenue decreased by -5.17%.
Measured over the past years, BYND shows a small growth in Revenue. The Revenue has been growing by 1.85% on average per year.
EPS 1Y (TTM)34.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.53%
Revenue 1Y (TTM)-5.17%
Revenue growth 3Y-11.1%
Revenue growth 5Y1.85%
Sales Q2Q%-19.56%

3.2 Future

Based on estimates for the next years, BYND will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.55% on average per year.
BYND is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.16% yearly.
EPS Next Y21.58%
EPS Next 2Y17.32%
EPS Next 3Y13.08%
EPS Next 5Y14.55%
Revenue Next Year-13.59%
Revenue Next 2Y-6.7%
Revenue Next 3Y-3.84%
Revenue Next 5Y-1.16%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BYND Yearly Revenue VS EstimatesBYND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
BYND Yearly EPS VS EstimatesBYND Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BYND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BYND. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYND Price Earnings VS Forward Price EarningsBYND Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BYND Per share dataBYND EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8

4.3 Compensation for Growth

A more expensive valuation may be justified as BYND's earnings are expected to grow with 13.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.32%
EPS Next 3Y13.08%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BYND!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEYOND MEAT INC

NASDAQ:BYND (8/22/2025, 8:00:02 PM)

After market: 2.53 +0.08 (+3.27%)

2.45

+0.06 (+2.51%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners43.96%
Inst Owner Change2.75%
Ins Owners4.56%
Ins Owner Change-2.34%
Market Cap187.79M
Analysts47.5
Price Target2.69 (9.8%)
Short Float %37.49%
Short Ratio10.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.38%
Min EPS beat(2)-35.72%
Max EPS beat(2)-5.04%
EPS beat(4)1
Avg EPS beat(4)-19.53%
Min EPS beat(4)-46.83%
Max EPS beat(4)9.47%
EPS beat(8)1
Avg EPS beat(8)-13.6%
EPS beat(12)4
Avg EPS beat(12)-9.82%
EPS beat(16)4
Avg EPS beat(16)-24.85%
Revenue beat(2)0
Avg Revenue beat(2)-10.28%
Min Revenue beat(2)-10.39%
Max Revenue beat(2)-10.16%
Revenue beat(4)0
Avg Revenue beat(4)-5.79%
Min Revenue beat(4)-10.39%
Max Revenue beat(4)-1%
Revenue beat(8)2
Avg Revenue beat(8)-3.22%
Revenue beat(12)3
Avg Revenue beat(12)-3.98%
Revenue beat(16)3
Avg Revenue beat(16)-3.92%
PT rev (1m)-8.93%
PT rev (3m)-28%
EPS NQ rev (1m)-16.51%
EPS NQ rev (3m)-5.63%
EPS NY rev (1m)-6.19%
EPS NY rev (3m)-6.19%
Revenue NQ rev (1m)-12.83%
Revenue NQ rev (3m)-14.35%
Revenue NY rev (1m)-8.36%
Revenue NY rev (3m)-9.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.62
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.13
EYN/A
EPS(NY)-1.44
Fwd EYN/A
FCF(TTM)-1.63
FCFYN/A
OCF(TTM)-1.44
OCFYN/A
SpS3.93
BVpS-8.83
TBVpS-8.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.2%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.57%
FCFM N/A
ROA(3y)-33.92%
ROA(5y)-25.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.31%
GM growth 5Y-17.54%
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.04%
Cap/Sales 4.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.29
Quick Ratio 2.07
Altman-Z -2.56
F-Score3
WACC5.63%
ROIC/WACCN/A
Cap/Depr(3y)98.2%
Cap/Depr(5y)297.95%
Cap/Sales(3y)7.98%
Cap/Sales(5y)14.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.53%
EPS Next Y21.58%
EPS Next 2Y17.32%
EPS Next 3Y13.08%
EPS Next 5Y14.55%
Revenue 1Y (TTM)-5.17%
Revenue growth 3Y-11.1%
Revenue growth 5Y1.85%
Sales Q2Q%-19.56%
Revenue Next Year-13.59%
Revenue Next 2Y-6.7%
Revenue Next 3Y-3.84%
Revenue Next 5Y-1.16%
EBIT growth 1Y49.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.28%
EBIT Next 3Y19.88%
EBIT Next 5Y19.24%
FCF growth 1Y40.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.17%
OCF growth 3YN/A
OCF growth 5YN/A